GPT-56T 861 —
MUSE-SPK 835 -0.7%
GPT-56SC 828 -5.2%
QWEN-38X 824 —
CL-OP55X 822 —
GROK-46H 822 -5%
GPT-6A 820 —
GLM-5 784 -8.4%
CL-FAB5H 743 -5.6%
KIMI-K3X 742 -8.4%
CL-OP5H 720 -5.8%
CL-OP5X 709 -18%
CL-OP46H 698 -5.9%
CL-OP47H 690 -5.9%
GEM-38FH 677 +0.1%
GEM-37FH 657 -24%
GPT-56S 622 —
CL-OP47 582 -0.7%
GPT-55H 582 —
INKL 531 —
GEM-31P 513 —
GEM-3P 499 —
CL-OP46 496 -0.2%
CL-OP48 490 —
GPT-56T 861 —
MUSE-SPK 835 -0.7%
GPT-56SC 828 -5.2%
QWEN-38X 824 —
CL-OP55X 822 —
GROK-46H 822 -5%
GPT-6A 820 —
GLM-5 784 -8.4%
CL-FAB5H 743 -5.6%
KIMI-K3X 742 -8.4%
CL-OP5H 720 -5.8%
CL-OP5X 709 -18%
CL-OP46H 698 -5.9%
CL-OP47H 690 -5.9%
GEM-38FH 677 +0.1%
GEM-37FH 657 -24%
GPT-56S 622 —
CL-OP47 582 -0.7%
GPT-55H 582 —
INKL 531 —
GEM-31P 513 —
GEM-3P 499 —
CL-OP46 496 -0.2%
CL-OP48 490 —
← Back to feed

Anthropic Commits $200M With the Gates Foundation to Vaccines, Global Health, and K-12 Education

Anthropic has announced a $200 million partnership with the Bill & Melinda Gates Foundation, allocating grant funding, Claude usage credits, and engineering support across four areas: global health, life sciences, education, and economic mobility. The commitment runs four years and is structured to reach populations that commercial AI deployment won’t reach on its own.

The largest piece targets health outcomes in low- and middle-income countries, where roughly 4.6 billion people lack access to essential health services. Anthropic’s Beneficial Deployments team will work directly with health ministries on workforce deployment, supply chain management, and outbreak detection using AI-assisted health-intelligence data.

Drug and Vaccine Discovery

The most technically specific commitment is in neglected disease research. Anthropic will use Claude to screen potential vaccine candidates computationally — starting with polio and HPV — before pre-clinical development begins. The goal is to compress early-stage timelines by filtering candidates faster than wet-lab methods allow. A parallel track targets new therapies for preeclampsia, which causes dangerous pregnancy complications. HPV kills approximately 350,000 people annually, 90% of them in low- and middle-income countries.

Anthropic is also partnering with the Institute for Disease Modeling (IDM), a research group within the Gates Foundation, to improve forecasts that determine where malaria and tuberculosis treatments are deployed. Claude will be integrated into IDM’s forecasting tools to make outputs accessible to practitioners who are not modeling specialists.

Education

On education, the partnership will produce public goods first: model benchmarks, datasets, and knowledge graphs for math tutoring, college advising, and curriculum design. The first of these will be released publicly later in 2026. Deployed tools will provide evidence-based tutoring to K-12 students in the US, with parallel programs supporting foundational literacy and numeracy in sub-Saharan Africa and India through the Global AI for Learning Alliance (GAILA).

Economic Mobility

The economic mobility pillar targets smallholder farmers — approximately two billion people whose incomes depend on agriculture — through agriculture-specific model improvements and local crop datasets released as public goods. In the US, the work centers on portable skills records, career guidance for workforce re-entrants, and program-to-employment outcome tracking.

Context

The partnership is the most concrete implementation of Anthropic’s “Beneficial Deployments” team, which has existed quietly to manage discounted Claude access for nonprofits and educational institutions. Bringing the Gates Foundation as a $200M co-investor gives the program scale and credibility it hasn’t had before. It also positions Anthropic alongside OpenAI, which has been building similar education infrastructure through its Estonia and global university deployments — and competing directly with Google’s AI for Social Good programs.

Anthropic said it plans to publish its thinking on beneficial deployments and report on program impact as the partnership scales. The Gates Foundation published a parallel statement on the same day.